# PROMETHEUS BIOSCIENCES INC (RXDX)

> Institutional ownership reported to the SEC as of Q2 2023, from Form 13F filings. Source: https://holderbook.com/stocks/RXDX/

- Reporting holders: 4
- Reported value: $67.1M
- Held through calls: 20.3%
- Held through puts: 76.8%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Maven Securities LTD](https://holderbook.com/funds/1633046-maven-securities-ltd/) | $65.0M | 0 | 1.0% | 1 |
| [UBS ASSET MANAGEMENT AMERICAS INC](https://holderbook.com/funds/861177-ubs-asset-management-americas-inc/) | $2.0M | 18,448 | 0.0% | 4 |
| [SIMPLEX TRADING, LLC](https://holderbook.com/funds/1488542-simplex-trading-llc/) | $113.0K | 0 | 0.0% | 7 |
| [FinTrust Capital Advisors, LLC](https://holderbook.com/funds/1622001-fintrust-capital-advisors-llc/) | $1.4K | 13 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2023 | 4 | $67.1M |
| Q1 2023 | 224 | $4.7B |
| Q4 2022 | 226 | $4.7B |
| Q3 2022 | 149 | $2.0B |
| Q2 2022 | 116 | $885.0M |
| Q1 2022 | 103 | $1.1B |
| Q4 2021 | 81 | $1.1B |
| Q3 2021 | 51 | $573.2M |
| Q2 2021 | 49 | $667.0M |
| Q1 2021 | 41 | $425.7M |